However, in the context of NAFLD and T2DM, hepatocytes exhibit impaired sensitivity to glucagon—a phenomenon referred to as hepatic glucagon resistance—which leads to compensatory hypersecretion of glucagon from pancreatic α-cells (49). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.